Showing results (131-140 of 147) with videos related to
Sort By:
Pageof 15
Cancer|August 2, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in ChinaChunwei Xu, Zhanhong Chen, Yuanli Xia, et al.Thoracic Cancer|October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitorWenxian Wang, Qian Wang, Chunwei Xu, et al.Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.Journal of Thoracic Disease|May 22, 2025
Expert consensus on cancer treatment-related lung injuryXinqing Lin, Hui Guo, Wei Zhao, et al.Thoracic Cancer|November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancerDingzhi Huang, Gen Lin, Qian Chu, et al.Cancer Biology & Medicine|April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationHuijing Feng, Yang Xia, Wenxian Wang, et al.Thoracic Cancer|July 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesotheliomaQian Wang, Chunwei Xu, Wenxian Wang, et al.Thoracic Cancer|September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaChunwei Xu, Lu Si, Wenxian Wang, et al.Pageof 15